The War on Vaping has consisted of one battle after another in recent years, but a new survey conducted by Ohio State University in Columbus may be showing a proverbial light at the end of the tunnel. Or is it?
When Dr. Peter Shields and his team of scientists surveyed 2,000 people under the age of 35, more than 44 percent of them believed e-cigs and vaping to be significantly safer and healthier that convectional tobacco smoking. The number jumped even higher to 54 percent when only the men were questioned.
And the OSU team isn’t stopping there. They are also recruiting new participants for two more clinic studies that are currently underway. Volunteers must be otherwise healthy, current tobacco users who agree to let the physicians monitor the positive and/or negative health effects of e-cigs and vaping on various functions of the body. Project 1 will focus on the impacts to lung health. And Project 2 focuses on potential exposure to cancer-causing chemicals and toxins. Lucky participants must live in Columbus, Ohio, but they also get lots of free vape gear.
Is OSU a friend or foe of vaping?
For those in the vaping community who are about to cheer for the scientists at OSU, please hold the applause. It is important to note that these OSU studies are being funded by the FDA and the National Cancer Institute – two organizations that are not usually considered advocates of the vaping industry. Furthermore, Dr. Sheilds is making some rather public statements that clearly have a decided slant against electronic cigarettes, in general.
“There is minimal data available regarding the direct health effects of e-cig use or vaping, but these products have gained rapid popularity among existing smokers and non-smokers alike, including young adults…We are concerned that people assume these products have fewer negative health effects as compared with cigarettes and other tobacco products. The reality is that they are still a tobacco product and people are still inhaling potentially harmful chemicals. They should not be considered a ‘safer’ option until science has the opportunity to catch up with the consumer market.”
Can OSU’s Dr. Sheilds and his research team be completely unbiased and open-minded when conducting their next two clinic trials? Or will this be yet another team of ‘scientist puppets” whose strings are secretly being manipulated by the FDA? Only time will tell.
To learn more about these OSU research studies, visit cancer.osu.edu/ecigs.
Article Credit: Matt Rowland